Gastroenterology
Volume 136, Issue 3 , Pages 863-871 , March 2009

Low Cerebral Oxygen Consumption and Blood Flow in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy

  • Peter Iversen

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Michael Sørensen

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Lasse Kristoffer Bak

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Helle Sønderby Waagepetersen

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Manouchehr Seyedi Vafaee

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Center of Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Per Borghammer

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Center of Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Kim Mouridsen

      Affiliations

    • Center of Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Svend Borup Jensen

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Hendrik Vilstrup

      Affiliations

    • Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Arne Schousboe

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Peter Ott

      Affiliations

    • Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Albert Gjedde

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Center of Functionally Integrative Neuroscience (CFIN), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Susanne Keiding

      Affiliations

    • PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark
    • Corresponding Author InformationReprint requests Address requests for reprints to: Susanne Keiding, MD, Department of Medicine V, Aarhus University Hospital, DK- 8000 Aarhus, Denmark. Phone: +45 8949 3031; fax: +45 8949 3020

Received 22 August 2008 ,Accepted 23 October 2008.

References 

  1. Sherlock S, Summerskill WH, White LP, et al. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet. 1954;267:453–457
  2. Lockwood AH, McDonald JM, Reiman RE, et al. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest. 1979;63:449–460
  3. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987;67:440–519
  4. Butterworth RF, Giguere J-F, Michaud J, et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol. 1987;6:1–12
  5. Jones EA, Basile AS. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?. Metab Brain Dis. 1998;13:351–360
  6. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17:221–227
  7. Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int. 2004;44:185–198
  8. Ott P, Clemmesen O, Larsen FS. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int. 2005;47:13–18
  9. Lai JC, Cooper AJ. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem. 1986;47:1376–1386
  10. Zwingmann C, Chatauret N, Leibfritz D, et al. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology. 2003;37:420–428
  11. Keiding S, Sørensen M, Bender D, et al. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology. 2006;43:42–50Correction in Hepatology 2006;44:1056
  12. Johansen ML, Bak LK, Schousboe A, et al. The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int. 2007;50:1042–1051
  13. Fazekas JF, Ticktin HE, Wilfred R, et al. Cerebral metabolism in hepatic insufficiency. Am J Med. 1956;21:843–849
  14. Posner JB. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest. 1960;39:1246–1258
  15. Morgan MY, Jakobovits AW, James IM, et al. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 1980;78:663–670
  16. Philips BJ, Armstrong IR, Pollock A, et al. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. Hepatology. 1998;27:369–376
  17. Strauss GI, Møller K, Larsen FS, et al. Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transpl. 2003;9:1244–1252
  18. Almdal T, Schroeder T, Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scand J Gastroenterol. 1989;24:299–303
  19. Kety SS, Schmidt CF. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest. 1948;27:476–483
  20. Kato A, Suzuki K, Kaneta H, et al. Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography. Hepatol Res. 2000;17:237–245
  21. Lockwood AH, Yap EW, Rhoades HM, et al. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab. 1991;11:331–336
  22. Ikeda K, Tsuji H, Azuma K, et al. Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography. [in Japanese] Fukuoka Igaku Zasshi. 2001;92:306–314
  23. Iversen P, Hansen DA, Bender D, et al. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with overt hepatic encephalopathy. Eur J Nucl Med Mol Imaging. 2006;33:810–816
  24. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721
  25. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773
  26. Elsass P, Christensen SE, Mortensen EL, et al. Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver. 1985;5:29–34
  27. Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution. Acta Physiol Scand. 1963;58:162–172
  28. Tygstrup N. Effect of sites for blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest. 1977;37:333–338
  29. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649
  30. Thompson CJ, Kecani S, Boelen S. Evaluation of a neck shield for use during neurological studies with a whole-body PET scanner. IEEE Trans Nucl Sci. 2001;48:1512–1517
  31. van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta. 1974;56:151–157
  32. Munk OL, Keiding S, Bass L. A method to estimate catheter dispersion and to calculate dispersion-free blood time-activity curves. Med Phys. 2008;35:3471–3481
  33. Ohta S, Meyer E, Thompson CJ, et al. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab. 1992;12:179–192
  34. Ohta S, Meyer E, Fujita H, et al. Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values. J Cereb Blood Flow Metab. 1996;16:765–780
  35. Talairach J, Tournoux P. Co-planar Stereotactic Atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging. Stuttgart, NY: Georg Thieme Verlag; 1988;
  36. Grabner G, Janke A, Budge M, et al. Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. In:  Larsen R,  Nielsen M,  Sparring J editor. Medical Image Computing and Computer-Assisted Intervention. Berlin/Heidelberg, Germany: Springer; 2006;p. 58–66
  37. Collins DL, Neelin P, Peters TM, et al. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18:192–205
  38. Ribeiro MJ, Almeida P, Strul D, et al. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. Eur J Nucl Med. 1999;26:758–766
  39. van der Weerdt AP, Klein LJ, Boellaard R, et al. Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. J Nucl Med. 2001;42:1622–1629
  40. Lawson CL, Hanson RJ. Solving least squares problems. Englewood Cliffs, NJ: Prentice Hall; 1974;
  41. Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab. 1984;4:629–632
  42. Worsley KJ, Liao CH, Aston J, et al. A general statistical analysis for FMRI data. Neuroimage. 2002;15:1–15
  43. Worsley KJ, Marrett S, Neelin P, et al. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp. 1996;4:58–73
  44. Ahl B, Weissenborn K, van den Hoff J, et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology. 2004;40:73–79
  45. Borghammer P, Jonsdottir KY, Cumming P, et al. Normalization in PET group comparison studies—the importance of a valid reference region. Neuroimage. 2008;40:529–540
  46. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization (Normal values and effect of age). Brain. 1990;113:27–47
  47. Sakoh M, Ostergaard L, Røhl L, et al. Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs. J Neurosurg. 2000;93:647–657
  48. Ahboucha S, Butterworth R. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis. 2004;19:331–343

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Danish Medical Research Council (271-06-0357, 271-07-0267), the Alfred Benzon Foundation, the Carlsberg Foundation, Aarhus University, and the Helga and Peter Kornings Foundation.

PII: S0016-5085(08)01895-7

doi: 10.1053/j.gastro.2008.10.057

Gastroenterology
Volume 136, Issue 3 , Pages 863-871 , March 2009

Article Tools

* Image Usage & Resolution